Wealthfront’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $1.25M | Buy |
6,487
+199
| +3% | +$38.3K | 0.01% | 210 |
|
|
2018
Q2 | $1.07M | Sell |
6,288
-4,985
| -44% | -$847K | 0.01% | 235 |
|
|
2018
Q1 | $1.84M | Buy |
11,273
+1,166
| +12% | +$190K | 0.02% | 146 |
|
|
2017
Q4 | $1.52M | Buy |
10,107
+1,584
| +19% | +$237K | 0.02% | 156 |
|
|
2017
Q3 | $1.3M | Sell |
8,523
-3
| -0% | -$456 | 0.02% | 151 |
|
|
2017
Q2 | $1.1M | Buy |
8,526
+1,462
| +21% | +$188K | 0.02% | 142 |
|
|
2017
Q1 | $772K | Buy |
+7,064
| New | +$772K | 0.01% | 159 |
|
|
2016
Q4 | – | Sell |
-4,409
| Closed | -$385K | – | 401 |
|
|
2016
Q3 | $385K | Sell |
4,409
-331
| -7% | -$28.9K | 0.01% | 231 |
|
|
2016
Q2 | $408K | Buy |
+4,740
| New | +$408K | 0.01% | 200 |
|
|
2016
Q1 | – | Sell |
-3,447
| Closed | -$434K | – | 359 |
|
|
2015
Q4 | $434K | Buy |
3,447
+382
| +12% | +$48.1K | 0.02% | 160 |
|
|
2015
Q3 | $319K | Sell |
3,065
-1,140
| -27% | -$119K | 0.01% | 189 |
|
|
2015
Q2 | $519K | Buy |
4,205
+819
| +24% | +$101K | 0.02% | 104 |
|
|
2015
Q1 | $399K | Buy |
3,386
+641
| +23% | +$75.5K | 0.02% | 106 |
|
|
2014
Q4 | $326K | Buy |
2,745
+610
| +29% | +$72.4K | 0.02% | 110 |
|
|
2014
Q3 | $240K | Buy |
2,135
+495
| +30% | +$55.6K | 0.02% | 124 |
|
|
2014
Q2 | $162K | Buy |
1,640
+1,486
| +965% | +$147K | 0.01% | 133 |
|
|
2014
Q1 | $11K | Buy |
+154
| New | +$11K | ﹤0.01% | 489 |
|